Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in… US FDA label
Use: INDICATIONS AND USAGE OCUFLOX ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: CONJUNCTIVITIS: Gram-positive… US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per ml ophthalmic solution: 3 mg/1 mg
Registered products in the Philippines
7 products registered with the Food and Drug Administration (FDA) Philippines list Dexamethasone + Ofloxacin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products7
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
FoxadexOfloxacin + Dexamethasone | 0.3% w/v / 0.1% w/v Ophthalmic Solution10 mL Opaque plastic bottle Box of 1's | Rx | Indiana Ophthalmics LLPIndia | Pharmabiz Solutions, Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5915-02 | Dec 23, 2029 | |
IdexineOfloxacin + Dexamethasone | 0.3% w/v / 0.1% w/v Ophthalmic Solution10 mL Opaque plastic bottle (Box of 1's) | Rx | Indiana Ophthalmics LLPIndia | I-senz Medical Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5915 | Dec 23, 2029 | |
NoneOfloxacin + Dexamethasone | 0.3 % w/v / 0.1 % w/v Ophthalmic Solution10 mL Opaque plastic bottle / (Box of 1’s) | Rx | Indiana Ophthalmics LLPIndia | Celsus Pharmaceuticals Phils., Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5915-05 | Dec 23, 2029 | |
NoneOfloxacin + Dexamethasone | 0.3% w/v / 0.1% w/v Ophthalmic Solution10 mL Opaque Plastic Bottle (Box of 1's) | Rx | Indiana OphthalmicsIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5915-01 | Dec 23, 2029 | |
Oflaz-DMOfloxacin + Dexamethasone | 0.3% w/v / 0.1% w/v Ophthalmic Solution10 mL Opaque Plastic Bottle (Box of 1's) | Rx | Indiana Ophthalmics LLPIndia | Ophtha Pharma Traders Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5915-04 | Dec 23, 2029 | |
OflodexOfloxacin + Dexamethasone (as sodium phosphate) | 3 mg/1 mg per mL (0.3% w/v / 0.1 % w/v) Ophthalmic Solution (Eye Drop)10mL Opaque Collapsible Plastic Bottle with Nozzle. and Cap x 1's (Box of 1's) | Rx | Indiana OphthalmicsIndia | Aglobal Care, Inc. | DRP-13294 | Jan 18, 2028 | |
OphthasoneOfloxacin + Dexamethasone | 0.3% w/v / 0.1% w/v Ophthalmic Solution10 mL Opaque Plastic Bottle (Box of 1's) | Rx | Indiana Ophthalmics LLPIndia | Ophthamed Pharma Corp.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5915-03 | Dec 23, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .